- Home
- RBOT vs MDAI Comparison
RBOT vs MDAI Comparison
Compare RBOT & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- MDAI
- Stock Information
- Founded
- RBOT 2014
- MDAI 2013
- Country
- RBOT United States
- MDAI United States
- Employees
- RBOT N/A
- MDAI N/A
- Industry
- RBOT Medical Specialities
- MDAI Medical/Dental Instruments
- Sector
- RBOT Health Care
- MDAI Health Care
- Exchange
- RBOT Nasdaq
- MDAI Nasdaq
- Market Cap
- RBOT 33.9M
- MDAI 34.8M
- IPO Year
- RBOT N/A
- MDAI N/A
- Fundamental
- Price
- RBOT $7.53
- MDAI $1.65
- Analyst Decision
- RBOT Hold
- MDAI Strong Buy
- Analyst Count
- RBOT 2
- MDAI 2
- Target Price
- RBOT $9.25
- MDAI $4.75
- AVG Volume (30 Days)
- RBOT 13.0K
- MDAI 271.9K
- Earning Date
- RBOT 05-12-2025
- MDAI 05-13-2025
- Dividend Yield
- RBOT N/A
- MDAI N/A
- EPS Growth
- RBOT N/A
- MDAI N/A
- EPS
- RBOT N/A
- MDAI N/A
- Revenue
- RBOT N/A
- MDAI $29,962,000.00
- Revenue This Year
- RBOT N/A
- MDAI N/A
- Revenue Next Year
- RBOT N/A
- MDAI $86.26
- P/E Ratio
- RBOT N/A
- MDAI N/A
- Revenue Growth
- RBOT N/A
- MDAI 55.21
- 52 Week Low
- RBOT $4.27
- MDAI $0.82
- 52 Week High
- RBOT $19.00
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- RBOT 50.14
- MDAI 66.58
- Support Level
- RBOT $6.61
- MDAI $1.57
- Resistance Level
- RBOT $7.87
- MDAI $1.73
- Average True Range (ATR)
- RBOT 0.56
- MDAI 0.09
- MACD
- RBOT -0.02
- MDAI 0.04
- Stochastic Oscillator
- RBOT 42.64
- MDAI 82.61
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.